Luis C. Pena

CIK: 0001620548

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)2 (28.6%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)3 (42.9%)

Compensation grants

Other (G, F, J, C, D, …)2 (28.6%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

EVMN

Evommune, Inc.

DirectorOfficer

Discretionary Trading P&L

Holdings

Transaction History (7 total)

EVMN
Evommune, Inc.
Sep 30, 2026
Award(A)
Direct
1.1K shares at avg. $7.02$8K
EVMN
Evommune, Inc.
Jun 22, 2026
Sale(S)
Direct
7.4K shares at avg. $22.71$169K
EVMN
Evommune, Inc.
Jun 1, 2026
Sale(S)
Direct
16.8K shares at avg. $22.74$382K
EVMN
Evommune, Inc.
Apr 16, 2026
Award(A)
Employee Stock Option (Right to Buy)
Direct
291.4K shares-
EVMN
Evommune, Inc.
Dec 9, 2025
Tax Payment(F)
Direct
28.1K shares at avg. $17.84$502K
EVMN
Evommune, Inc.
Nov 7, 2025
Conversion(C)
Direct
24.2K shares-
EVMN
Evommune, Inc.
Nov 5, 2025
Award(A)
Employee Stock Option (Right to Buy)
Direct
796.8K shares-

		Type	Shares	Price		Ownership
Sep 30, 2026	EVMN Evommune, Inc.	Award(A)	1,115	$7.02	$7,827	Direct
Jun 22, 2026	EVMN Evommune, Inc.	Sale(S)	7,438	$22.71	$168,917	Direct
Jun 1, 2026	EVMN Evommune, Inc.	Sale(S)	16,787	$22.74	$381,736	Direct
Apr 16, 2026	EVMN Evommune, Inc.	Award(A) Employee Stock Option (Right to Buy)	291,420	-	-	Direct
Dec 9, 2025	EVMN Evommune, Inc.	Tax Payment(F)	28,138	$17.84	$501,982	Direct
Nov 7, 2025	EVMN Evommune, Inc.	Conversion(C)	24,225	-	-	Direct
Nov 5, 2025	EVMN Evommune, Inc.	Award(A) Employee Stock Option (Right to Buy)	796,841	-	-	Direct

1-7 of 7 transactions

About Pena Luis C.

Pena Luis C. (SEC CIK 0001620548) files insider reports with the SEC as President & CEO of Evommune, Inc. (EVMN).

Signal8 holds 8 ownership filings by Pena Luis C. (1 Form 3, 7 Form 4), filed between Nov 5, 2025 and Oct 15, 2026. Those filings report 7 transactions, from Nov 5, 2025 to Sep 30, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Pena Luis C.'s filings is in PALO ALTO, CA.

Recent filings by Pena Luis C.

Sep 30, 2026: Grant or award of EVMN shares (Form 4, code A).
Jun 22, 2026: Open-market sale of EVMN shares (Form 4, code S).
Jun 1, 2026: Open-market sale of EVMN shares (Form 4, code S).
Apr 16, 2026: Grant or award of EVMN derivative securities (Form 4, code A).
Dec 9, 2025: Tax withholding of EVMN shares (Form 4, code F).

Other insiders filing for Evommune, Inc. (EVMN)

Carver Kyle, Chief Financial Officer
KIRSCH ARTHUR S, Director
Drew Janice Suzann, Chief of Dev. Operations
Patel Jeegar Pravinkumar, Chief Scientific Officer
MCGRAW BENJAMIN F III, Director
Cohen David E, Director

How to read Form 4 transaction codes